Skip to main content
SpringerLink
Log in

Mecasermin

Splenic-infarction, hypertrophy of nose and myelodysplasia: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bang P, et al. Effectiveness and safety of rhIGF-1 therapy in children: The European increlex growth forum database experience on behalf of the EU IGFD registry study group. Hormone Research in Paediatrics 83: 345-357, No. 5, 9 Jun 2015. Available from: URL: http://doi.org/10.1159/000371798 - Sweden

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mecasermin. Reactions Weekly 1633, 472 (2017). https://doi.org/10.1007/s40278-017-24740-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-24740-z

Search

Navigation